Triple-negative breast cancer molecular subtyping and treatment progress

Triple-negative breast cancer (TNBC), a specific subtype of breast cancer that does not express estrogen receptor (ER), progesterone receptor (PR), or human epidermal growth factor receptor 2 (HER-2), has clinical features that include high invasiveness, high metastatic potential, proneness to relap...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Li, Duan, Jiang-Jie, Bian, Xiu-Wu, Yu, Shi-cang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285581/
https://www.ncbi.nlm.nih.gov/pubmed/32517735
http://dx.doi.org/10.1186/s13058-020-01296-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7285581/
https://www.ncbi.nlm.nih.gov/pubmed/32517735
http://dx.doi.org/10.1186/s13058-020-01296-5

Ejemplares similares